Spondyloarthropathies
From the Journals
AS inflammatory back pain criteria fall short in PsA
The presence or absence of back pain in patients with axial radiologic involvement did not affect prognosis, suggesting the value of considering...
Conference Coverage
Biosimilar switch accepted by most rheumatic disease patients
LIVERPOOL, ENGLAND – With health systems increasingly favoring biosimilars to biologics, the question is, are patients happy to make the switch?...
Conference Coverage
Ankylosing spondylitis progression slowed when NSAIDs added to TNFi
Latest News
Methotrexate proves largely ineffective for maintaining peripheral SpA remission
AMSTERDAM – More than half of patients who started golimumab (Simponi) within 12 weeks of symptom onset had complete remission of SpA.
Conference Coverage
Checkpoint inhibitors in autoimmune disease: More flares, better cancer outcomes
AMSTERDAM –
Conference Coverage
Biologics improve axial spondyloarthritis patients’ work performance
Video
Observational data can’t answer question of inhibiting ankylosing spondylitis progression
AMSTERDAM –
Conference Coverage
TNF inhibitor may protect against axSpA sacroiliac joint progression
AMSTERDAM – In patients with axial spondyloarthritis, TNF inhibitor therapy is associated with slowing of sacroiliac joint radiographic...
Conference Coverage
Ankylosing spondylitis diagnosis linked to self-harm attempts
AMSTERDAM – Although a rare event, there is an increased risk of deliberate self-harm among those newly-diagnosed ankylosing spondylitis.
Conference Coverage
Axial SpA diagnostic strategies need not be sex-specific
AMSTERDAM – Imaging and HLA-B27 tests are key elements to identify early axial spondyloarthritis in both men and women.